drugset / Trial / NCT00901199

Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload

NCT00901199

Phase 2 Completed 22 enrolled Elliott Vichinsky
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study looking at the safety and efficacy of giving combination chelation with deferasirox and deferoxamine. The hypothesis is that combination chelation is safe in decreasing overall iron in patients with thalassemia.

Timeline

Start
2007-09
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Deferasirox Unknown 20 mg/kg
Subject Deferasirox Unknown 30 mg/kg
Subject Deferoxamine Other / unclassified 50 mg/kg